Cited by 26Cardiac Valve Diseases and TreatmentsECG Monitoring and AnalysisArtificial Intelligence in Healthcare

Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international study

Open access
Liang, Yixiu, Sau, Arunashis, Zeidaabadi, Boroumand, Barker, Joseph, Patlatzoglou, Konstantinos, Pastika, Libor, Sieliwonczyk, Ewa, Whinnett, Zachary +10 more·2025·European Heart Journal

Abstract

Background and Aims: Valvular heart disease (VHD) is a significant source of morbidity and mortality, though early intervention can improve outcomes. This study aims to develop artificial intelligence-enhanced electrocardiography (AI-ECG) models to diagnose and predict future moderate or severe regurgitant VHDs (rVHDs), including mitral regurgitation (MR), tricuspid regurgitation (TR), and aortic regurgitation (AR). Methods: The AI-ECG models were developed in a data set of 988 618 ECG and transthoracic echocardiogram pairs from 400 882 patients from Zhongshan Hospital, Shanghai, China. The AI-ECG models used a residual convolutional neural network with a discrete-time survival loss function. External evaluation was performed in outpatients from a secondary care data set from Beth Israel Deaconess Medical Center, Boston, USA, consisting of 34 214 patients with linked echocardiography. Results: In the internal test set, the AI-ECG models accurately predicted future significant MR [C-index 0.774, 95% confidence interval (CI) 0.753–0.792], AR (0.691, 95% CI 0.657–0.720), and TR (0.793, 95% CI 0.777–0.808). In age- and sex-adjusted Cox models, the highest risk quartile had a hazard ratio (HR) of 7.6 (95% CI 5.8–9.9, P < .0001) for risk of future significant MR, compared with the lowest risk quartile. For future AR and TR, the equivalent HRs were 3.8 (95% CI 2.7–5.5) and 9.9 (95% CI 7.5–13.0), respectively. These findings were confirmed in the transnational external test set. Imaging association analyses demonstrated AI-ECG predictions were associated with subclinical chamber remodelling. Conclusions: This study developed AI-ECG models to diagnose and predict rVHDs and validated the models in a transnational and ethnically distinct cohort. The AI-ECG models could be utilized to guide surveillance echocardiography in patients at risk of future rVHDs, to facilitate early detection and intervention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehaf448

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Valvular and composite SHD AI-ECG models are promising for referral enrichment.

    “Valvular and composite SHD models are promising for referral enrichment”

    From AI-ECG for Echocardiography Triage in Structural Heart Disease: Evidence, Implementation, and Future Directions (2026) · cites this paper as [24]

    The Discussion says the valvular AI-ECG models could guide surveillance echocardiography for patients at risk of regurgitant valve disease, supporting the proposed referral use. The paper does not evaluate a composite structural heart disease (SHD) model, so that part of the claim is unsupported. Page numbers are unavailable in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Liang, Y., Sau, A., Zeidaabadi, B., Barker, J., Patlatzoglou, K., Pastika, L., Sieliwonczyk, E., Whinnett, Z., Peters, N. S., Yu, Z., Liu, X., Wang, S., Lu, H., Kramer, D. B., Waks, J. W., Su, Y., Ge, J., & Ng, F. S.
Affiliations
  • Fudan University (CN)
  • Imperial College Healthcare NHS Trust (GB)
  • Hammersmith Hospital (GB)
  • National Heart and Lung Institute, Imperial College London, Hammersmith Hospital , Du Cane Road, London W12 0NN ,
  • Shanghai Medical College of Fudan University (CN)
  • Medtronic (China) (CN)
  • Beth Israel Deaconess Medical Center (US)
Corresponding author
  • Sau, Arunashis
  • Ge, Junbo
  • Ng, Fu Siong
Venue
European Heart Journal
Published
2025-07-16
Volume
46
Issue
44
Pages
4823-4837
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W4412488540
Cited by
26
References
43
Citations by year
2026: 16 · 2025: 10
FWCI
18.16
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
  • Shanghai Municipal Key Clinical Specialty (shslczdzk01701)
  • Fudan University AI4S Project (FudanX24AI056)
  • British Heart Foundation (FS/CRTF/21/24183)
  • NIHR Academic Clinical Lectureship
  • Medical Research Council (MR/Y000803/1)
  • BHF (RG/F/22/110078, RE/18/4/34215)
  • EJP RD Research Mobility Fellowship
  • National Institute for Health Research Imperial Biomedical Research Centre
  • Imperial’s BHF Centre (RE/18/4/34215, RE/24/130023)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › ECG Monitoring and Analysis
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
mitral regurgitation, tricuspid regurgitation, aortic regurgitation, residual convolutional neural network, risk prediction, transthoracic echocardiography, early detection
MeSH terms
Aged, Aortic Valve Insufficiency, Artificial Intelligence, Echocardiography, Electrocardiography, Female, Heart Valve Diseases, Humans, Male, Middle Aged, Mitral Valve Insufficiency, Tricuspid Valve Insufficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review